Literature DB >> 17333725

High-performance liquid chromatographic method for the determination of ivermectin in plasma.

K Na-Bangchang1, V Banmairuroi, A Choemung.   

Abstract

A simple, sensitive, selective and reproducible method based on reversed-phase chromatography was developed for the determination of ivermectin in human plasma. The internal standard (moxidectin) was separated from ivermectin on a Hypersil Gold C18 column (150 x 4.6 mm, 5 microm particle size), with retention time of 3.7 and 7.0 minutes, respectively. Fluorescence detection was set at an excitation and emission wavelength of 365 and 475 nm, respectively. The mobile phase consisted of acetonitrile, methanol and distilled water (50:45:5, v/v/v), running through the column at a flow rate of 1.5 ml/minute. The chromatographic analysis was operated at 25 degrees C. Sample preparation (100 microl plasma) was done by a single step protein precipitation with acetonitrile, followed by derivatization with 100 microl of N-methylimidazole solution in acetonitrile (1:1, v/v) and 150 microl of trifluoroacetic anhydrous solution in acetonitrile (1:2, v/v). Calibration curve over the concentration range of 20-8000 ng/ml plasma was linear with correlation coefficient better than 0.995. The precision of the method based on within-day repeatability and reproducibility (day-to-day variation) was below 15% (coefficient of variation) Good accuracy was observed for both intra-day and inter-day assays, as indicated by the minimal deviation of mean values found with measured samples from that of the theoretical values (below +15%). Limit of quantification was 0.02 ng using 100 microl sample. The mean recovery for ivermectin and the internal standard was greater than 90%. The method was free from interference from endogenous substances and commonly used drugs. The method appears to be robust and has been applied to the investigation of plasma concentration vs time profile of ivermectin in five healthy Thai volunteers following a single oral dose of 200 microg ivermectin/kg body weight.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17333725

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

1.  Determination of ivermectin in medicated feeds by liquid chromatography with fluorescence detection.

Authors:  Konrad Pietruk; Piotr Jedziniak
Journal:  ScientificWorldJournal       Date:  2013-12-19

2.  Electrochemical Detection of Ivermectin Used for the Treatment of COVID-19 with Glutardialdehyde-Modified Glassy Carbon Electrode.

Authors:  Berna Koçak; Yeliz İpek
Journal:  Electrocatalysis (N Y)       Date:  2022-01-05       Impact factor: 2.933

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.